Yong Yu - 27 Aug 2025 Form 4 Insider Report for GENELUX Corp (GNLX)

Role
SVP, Clinical Development
Signature
/s/ Yong Yu
Issuer symbol
GNLX
Transactions as of
27 Aug 2025
Transactions value $
$0
Form type
4
Date filed
29 Aug 2025, 16:30
Previous filing
11 Dec 2025
Next filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Yu Yong SVP, Clinical Development C/O GENELUX CORPORATION, 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE /s/ Yong Yu 2025-08-29 0001937482

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNLX Common Stock Award $0 +101K +209% $0.00 150K 27 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNLX Stock Option (Right to Buy) Award $0 +135K $0.00 135K 27 Aug 2025 Common stock 135K $3.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter.
F2 Includes 916 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan.
F3 The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter.